Location History:
- Nagoya, JA (1977)
- Matsumoto, JA (1976 - 1978)
- Matsumoto, JP (1980 - 1986)
- Kanbayashi, JP (1986)
- Nagano, JP (1984 - 1989)
Company Filing History:
16 out of 176 
6 out of 575 
1 out of 1 Years Active: 1976-1989
Title: **The Innovative Contributions of Kinji Iizuka**
Introduction
Kinji Iizuka is a prominent inventor based in Nagano, Japan, known for his remarkable contributions to the field of pharmaceuticals. With a total of 19 patents to his name, Iizuka has been instrumental in developing novel therapeutic agents that address critical health issues, particularly in the realm of hypertension.
Latest Patents
Among his latest innovations are the following patents:
1. **Novel Amino Acid Derivatives** - This patent discloses novel amino acid derivatives useful as therapeutic agents. These compounds exhibit a human renin inhibitory effect when administered orally, making them effective for the treatment of hypertension, especially in cases associated with renin.
2. **Dipeptides as Renin Inhibitors** - In this patent, Iizuka describes dipeptides represented by a specific formula. These compounds show a strong inhibitory effect on human renin and are highly valued as therapeutically active agents for treating hypertension, particularly renin-associated hypertension.
Career Highlights
Throughout his career, Kinji Iizuka has collaborated with several noteworthy companies, including Kissei Pharmaceutical Co., Ltd. and Ono Pharmaceutical Co., Ltd. His work at these organizations has paved the way for many advancements in hypertension treatment, showcasing his significant impact on the pharmaceutical industry.
Collaborations
Kinji Iizuka has worked alongside notable colleagues such as Tetsuhide Kamijo and Kenji Akahane. Their collective expertise in pharmacology and medicine has contributed to successful research and the eventual development of innovative therapeutic agents.
Conclusion
In summary, Kinji Iizuka stands out as a highly influential inventor whose work has made substantial contributions to medical science, particularly in developing novel treatments for hypertension. His patents reflect a commitment to improving health outcomes, and his collaborations underscore the importance of teamwork in achieving breakthroughs in pharmaceutical innovations.